Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Healthtrust
Baxter
McKinsey
Medtronic
Covington
Dow
Chinese Patent Office
Novartis
Farmers Insurance

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,815,942

« Back to Dashboard

Which drugs does patent 7,815,942 protect, and when does it expire?

Patent 7,815,942 protects AZILECT and is included in one NDA.

This patent has twenty-six patent family members in eighteen countries.
Summary for Patent: 7,815,942
Title:Rasagiline formulations of improved content uniformity
Abstract:Disclosed are pharmaceutical preparations of R(+)-N-propargyl-1-aminoindan salts having enhanced content uniformity, processes for preparation of the compositions, and their uses.
Inventor(s): Peskin; Tirtza Berger (Raanana, IL)
Assignee: Teva Pharmaceutical Industries, Ltd. (Petach Tikva, IL)
Application Number:11/359,324
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use; Process;

Drugs Protected by US Patent 7,815,942

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Teva AZILECT rasagiline mesylate TABLET;ORAL 021641-001 May 16, 2006 AB RX Yes No ➤ Subscribe ➤ Subscribe Y Y TREATMENT OF PARKINSON'S DISEASE ➤ Subscribe
Teva AZILECT rasagiline mesylate TABLET;ORAL 021641-002 May 16, 2006 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y TREATMENT OF PARKINSON'S DISEASE ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,815,942

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2006216696 ➤ Subscribe
Brazil PI0608209 ➤ Subscribe
Canada 2600011 ➤ Subscribe
Canada 2901244 ➤ Subscribe
China 101123946 ➤ Subscribe
European Patent Office 1848402 ➤ Subscribe
Spain 2586412 ➤ Subscribe
Hong Kong 1103366 ➤ Subscribe
Israel 184033 ➤ Subscribe
Israel 244802 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
McKesson
Harvard Business School
Colorcon
Cerilliant
Merck
Farmers Insurance
Covington
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot